NEURODERMATITIS
Clinical trials for NEURODERMATITIS explained in plain language.
Never miss a new study
Get alerted when new NEURODERMATITIS trials appear
Sign up with your email to follow new studies for NEURODERMATITIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Shockwaves soothe skin: new hope for neurodermatitis itch?
Symptom relief CompletedThis study tested if a treatment called extracorporeal shockwave therapy can reduce itching in people with neurodermatitis, a chronic skin condition. 34 adults aged 55 to 75 took part. Researchers measured itching before and after treatment using a standard itch scale. The goal w…
Matched conditions: NEURODERMATITIS
Phase: NA • Sponsor: Cairo University • Aim: Symptom relief
Last updated May 26, 2026 07:31 UTC
-
New drug offers hope for unbearable itch in rare skin condition
Symptom relief CompletedThis study tested the drug dupilumab in 160 adults with prurigo nodularis, a condition causing intensely itchy skin bumps. Participants had severe itch that topical creams couldn't control. The goal was to see if dupilumab could reduce itch and clear skin lesions better than a pl…
Matched conditions: NEURODERMATITIS
Phase: PHASE3 • Sponsor: Sanofi • Aim: Symptom relief
Last updated May 26, 2026 07:29 UTC
-
New drug offers hope for uncontrollable itching in rare skin condition
Symptom relief CompletedThis study tested the drug dupilumab in 151 adults with prurigo nodularis, a skin condition causing intense itching and bumps. Participants had severe itch that topical treatments couldn't control. The goal was to see if dupilumab could reduce itch and clear skin lesions. Results…
Matched conditions: NEURODERMATITIS
Phase: PHASE3 • Sponsor: Sanofi • Aim: Symptom relief
Last updated May 26, 2026 07:24 UTC